| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | -0.2 | 0.3 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.19 | 0.3 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.18 | 0.3 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.18 | 0.3 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.18 | 0.3 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.16 | 0.4 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | -0.15 | 0.4 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.15 | 0.3 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0001 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.15 | 0.3 |